Investigating cognitive effects of aromatherapy on people with dementialiving in residential care facilities

Phase 3

Completed

• Conditions: Dementia; Neurological - Dementias

• Registration Number: ACTRN12605000290695
• Lead Sponsor: ACCMER

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

During the initial screening interview, potential participants will be invited to participate in the treatment arms of the study if they comply with the following criteria: They must have been resident in the nursing home for more than 3 months. Have an MMSE score of 25 or less, and be considered to have some degree of dementia by nursing staff and or diagnosis by geriatrician. Be in good health or have any concomitant diseases (such as hypertension, congestive heart failure, non-insulin-dependent diabetes mellitus and thyroid disorders) under control.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The 30 point Mini-Mental State Examination (MMSE)[Measured at week -2, baseline, week 12 and week 16]

Secondary Outcome Measures

Name	Time	Method
urses’ Observation Scale for Geriatric Patients (NOSGER).[Difference in baseline, repeated measures and endpoint scores.];Changes in the use of other medications related to cognitive and behavioural functions (for example, anti-depressants, anti-psychotics).[];Short Form 12 Quality of Life Scale.[Difference in baseline and end-point.]